Fenwick & West represented BioAge Labs in the transaction. BioAge Labs (BioAge) announced it completed the oversubscribed $170M Series D financing round led by Sofinnova Investments...
BioAge’s $170 Million Series D Financing Round
Cadence Neuroscience’s $26 Million Series B Financing
Fenwick represented Cadence Neuroscience on the deal. Cadence Neuroscience, a medical device company, announced that it has secured $26 million in Series B financing. The round was led by...